Onsdag 30 April | 11:18:18 Europe / Stockholm

Prenumeration

2025-04-30 08:04:00

Redeye provides an update following SSH's Q1 2025 were sales increased by 8% y/y to EUR5.4m, with a EBITDA margin of 4%. Operating cash flow was EUR0.7m and PrivX grew by 19%.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/